Jasmeen S. Merzaban
Papers
2
Total Citations
36
H-Index
2
About
Jasmeen S. Merzaban is a pioneering researcher at the intersection of nanomedicine and hematological oncology, with a primary focus on developing targeted therapies and disease models for leukemia. Her work centers on two transformative approaches: biofunctionalizing magnetic nanowires to precisely target and destroy leukemia cells while sparing healthy tissue, and engineering advanced three-dimensional bone marrow niche models using robotic bioprinting technology. In her highly cited 2018 study (21 citations), Merzaban demonstrated how magnetic nanomaterials can be functionalized to recognize and eliminate acute myeloid leukemia (AML) cells, offering a promising alternative to conventional chemotherapy. More recently, her 2023 work (15 citations) introduced an automated, controlled bioprinting system that recreates the complex bone marrow microenvironment, enabling researchers to study AML relapse mechanisms and test novel therapies in a physiologically relevant context. By combining nanotechnology with tissue engineering, Merzaban addresses critical challenges in cancer treatment—specifically, the need for targeted drug delivery and improved preclinical models that better predict clinical outcomes. Her innovative approaches are helping to bridge the gap between laboratory research and effective leukemia therapies, making her a notable figure in the fight against hematological malignancies.
Research Focus
Key Achievements
Top Papers
- 1
- 2